2Jakubowiez D J, Morno M J, Jakwbowicz S. Effects of metforimm on early-pregnancy loss in the polycystic ovary syndrome [J]. Jclin Endrocinol Metab, 2002,87 (2) : 524- 529.
3Sir-PetermannT. polycystic ovary syndrome, a pathway to type 2 diabetes [ J]. Natrition, 2005,21 ( 11-12 ) : 1160-1163.
6Trent M E, Rich M, Austin S B, et al. Ouality of life in adolescent girls with polycystic ovary syndrome [J]. Arch Pediatr Adolesc Med, 2002,156 (6) : 556-560.
4Franks S. Polysystic ovary syndrome: a changing respective [J]. Clinical Endocrinology, 1989,31 ( 1 ):87 ～ 120.
5Ferrman D,Callwey JD. Clinic assessment of body hair growth in Wdmen[J ]. J Clin- Endocrinol Metab, 1961, 21 :1440～ 1447.
6China Ghazeeri, Kutteh WH,Michael BA, et al. Effect of wsiglitazone on spontaneous and clorniphene citrate-induced ovulation inwomen with polycystic ovary syndrome[J]. Fertility and Sterility,2003,79(3) :562 - 566.
7Marx TL, Mehta AE. Polycystic ovary syndrome: pathogenesis and treatment over the short and long term [ J]. Cleve Clin J Med,2003,70( 1 ) :31 - 45.
8Mitkov M, Pehlivanov B, Terzieva D. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome[J]. Eur J ObstetGynecol Reprod Biol, 2006,126( 1 ) :93 - 98.
9Cataldo N A, Abbasi F, McLaughlin T L, et al. Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitozone[ J]. Fertil Steril,2001, 76(5) : 1057 - 1059.
